Purpose: The pharmacology, pharmacokinetics, efficacy, safety, drug interactions, dosage and administration, cost, and place in therapy of duloxetine for major depression, pain from diabetic ...

(Contraindications) Duloxetine is contraindicated in patients who also take mono amino oxidase inhibitors (MAOI) drugs. It should also be avoided by those allergic to the drug, with history of ...

The U.S. Food and Drug Administration (FDA) has been forced to recall thousands of bottles of the antidepressant medication ...

The combined effects of duloxetine and MAOIs have not been evaluated in humans to date. It is recommended that duloxetine not be used in combination with an MAOI or within 14 days of discontinuing ...

The FDA issued a recall notice for more than 7,000 bottles of duloxetine, a drug used to treat depression, anxiety, and nerve pain. The recalled lot may contain high levels of nitrosamines, a ...

Cymbalta faces a recall as the FDA detects harmful levels of N-nitroso-duloxetine, a chemical linked to cancer. Cymbalta, have been removed from shelves after the U.S. Food and Drug Administration ...

Over 7,000 bottles of the antidepressant duloxetine (Cymbalta ... ongoing phase II study of the investigational schizophrenia ...

Opens in a new tab or window Over 7,000 bottles of the antidepressant duloxetine (Cymbalta ... II study of the investigational schizophrenia drug ANAVEX3-71 showed dose-dependent improvements ...

At the start of the year Julie Hiener developed a dramatic stutter. She struggles to get the words out as she tells me: 'I ...

In 2019, about a year later, I sought help. Over the course of two years, I was prescribed a variety of different medications ...

Duloxetine came in second, with a slightly lower efficacy rate (23%) but the lowest dropout rate (37%). Pregabalin, on the ...

After the U.S. Food and Drug Administration recalled thousands of bottles of antidepressants it said contained high levels of a cancer-causing chemical, the federal agency has now upgraded the level ...